Catalyst
Slingshot members are tracking this event:
Cidara (CTDX) STRIVE Phase 2 study comparing CD101 to combination of Caspofungin and Oral Step Down Treatment for Candidemia set for July 2017 completion
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CDTX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 22, 2017
Occurred Source:
http://n33px2pjph02hfyxt1xmwn4m-wpengine.netdna-ssl.com/wp-content/uploads/2015/11/EHA-17_Ong-et-al_Poster-P645_Upload.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Candidemia, Phase 2
